<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&amp;ev=PageView&amp;noscript=1">
blog-hero.jpg
Compliance In Focus
Posted by John Lehmann on Wed, Sep 4, 2013

How Does IMARC Compare Regarding CV Clinical Trials?

check listOver the past few days, we have discussed five important traits of Contract Research Organization (CRO) when it comes to your Cardiovascular (CV) clinical trials. Because we regard CV clinical trials one of our core strengths, we thought it beneficial to sponsors to see just how IMARC compares. Read on for a look at our background and some of our recent successes.

IMARC Research, Inc, based in Cleveland, Ohio, was built upon a regulation-focused compliance foundation and has an expansive resume, which touts several therapeutic verticals, including CV.

Our company possesses a unique depth of knowledge and experience in the CV realm. Started by a nurse whose background includes coronary, medical, and surgical intensive care units and with a depth of nursing experience on the monitoring team, the level of expertise provided by IMARC during CV clinical trials will meet your approval.

Across the board, IMARC focuses on quality over quantity and strives to get it right the first time.

During a recent trial for a drug-eluting stent, IMARC:

  • Monitored 40+ sites in the US
  • Provided enrollment support
  • Audited each site/followed up on audit findings
  • Provided training and guidance to Japanese monitors
  • Audited 4 Japanese sites and sponsor
  • Monitored 3 sites in Canada for registry
  • Audited European sponsor for registry sites/oversight
  • Provided AE and device audits for sponsor
  • Audit Prepped for 5 sites receiving audit
  • Established presence with the sponsor for inspection

In addition, IMARC performed 37 visits in 40 days and achieved 30 percent enrollment target improvement for a peripheral stent study.

The company was happy to report no findings GLOBALLY. If you are interested in experiencing success like this, consider IMARC as your go-to CRO for CV clinical trials.

When choosing a CRO, rely on one that sets the bar high for itself and its employees. Each person is responsible for ensuring the company delivers the highest quality and best possible product to clients and, ultimately, to patients.

For more information on how you can help prepare your CV trials for success, please contact John Lehmann at 440.801.1540 or via e-mail at jlehmann@imarcresearch.com.

Download Drugs vs. Devices

Topics: Contract Research Organization, cardiovascular clinical trial, Clinical Research

imarc

Posts by Topic:

All